Jacobs Levy Equity Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Sell |
165,993
-108,300
| -39% | -$511K | ﹤0.01% | 805 |
|
|
2025
Q1 | $1.26M | Sell |
274,293
-196,433
| -42% | -$902K | 0.01% | 767 |
|
|
2024
Q4 | $2.25M | Sell |
470,726
-959,807
| -67% | -$4.6M | 0.01% | 572 |
|
|
2024
Q3 | $6.71M | Sell |
1,430,533
-55,729
| -4% | -$261K | 0.03% | 389 |
|
|
2024
Q2 | $8.4M | Buy |
1,486,262
+66,702
| +5% | +$377K | 0.03% | 360 |
|
|
2024
Q1 | $5.83M | Sell |
1,419,560
-10,290
| -0.7% | -$42.3K | 0.03% | 396 |
|
|
2023
Q4 | $6.03M | Buy |
1,429,850
+463,994
| +48% | +$1.96M | 0.03% | 393 |
|
|
2023
Q3 | $4.17M | Buy |
965,856
+156,896
| +19% | +$678K | 0.02% | 410 |
|
|
2023
Q2 | $5.33M | Sell |
808,960
-87,547
| -10% | -$577K | 0.03% | 378 |
|
|
2023
Q1 | $6.09M | Buy |
896,507
+46,162
| +5% | +$313K | 0.04% | 360 |
|
|
2022
Q4 | $6.28M | Sell |
850,345
-5,625
| -0.7% | -$41.6K | 0.04% | 354 |
|
|
2022
Q3 | $8.46M | Sell |
855,970
-175,525
| -17% | -$1.73M | 0.07% | 290 |
|
|
2022
Q2 | $11.2M | Buy |
1,031,495
+950,812
| +1,178% | +$10.4M | 0.09% | 259 |
|
|
2022
Q1 | $913K | Buy |
+80,683
| New | +$913K | 0.01% | 766 |
|
|
2021
Q4 | – | Sell |
-87,493
| Closed | -$1.5M | – | 1080 |
|
|
2021
Q3 | $1.5M | Sell |
87,493
-134,141
| -61% | -$2.3M | 0.01% | 671 |
|
|
2021
Q2 | $4.77M | Sell |
221,634
-486,854
| -69% | -$10.5M | 0.03% | 444 |
|
|
2021
Q1 | $10.6M | Sell |
708,488
-42,951
| -6% | -$645K | 0.08% | 283 |
|
|
2020
Q4 | $9.87M | Buy |
751,439
+303,295
| +68% | +$3.99M | 0.09% | 265 |
|
|
2020
Q3 | $4.33M | Buy |
+448,144
| New | +$4.33M | 0.04% | 374 |
|
|
2019
Q2 | – | Sell |
-12,900
| Closed | -$237K | – | 1034 |
|
|
2019
Q1 | $237K | Sell |
12,900
-84,635
| -87% | -$1.55M | ﹤0.01% | 872 |
|
|
2018
Q4 | $2.55M | Buy |
97,535
+61,910
| +174% | +$1.62M | 0.04% | 407 |
|
|
2018
Q3 | $818K | Sell |
35,625
-5,675
| -14% | -$130K | 0.01% | 682 |
|
|
2018
Q2 | $787K | Buy |
41,300
+6,410
| +18% | +$122K | 0.01% | 714 |
|
|
2018
Q1 | $588K | Buy |
34,890
+12,400
| +55% | +$209K | 0.01% | 752 |
|
|
2017
Q4 | $342K | Buy |
+22,490
| New | +$342K | 0.01% | 829 |
|